Proinflammatory cytokines in heart disease

Blood Purification

Volumn 19, Issue 3, 2001, Pages 314-321

  Dinarello, Charles A ^a,b   Pomerantz, Benjamin J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; IL ; Ischemia; Macrophages; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEPSIS; SEPTIC SHOCK;

CYTOKINES; HEART DISEASES; HUMANS; INFLAMMATION;

EID: 0035100076     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046960     Document Type: Conference Paper

References (48)

1. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function
2. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum
3. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility
4. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation
5. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy
6. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein
7. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
8. Adenosine decreases post-ischaemic cardiac TNF-alpha production: Anti-inflammatory implications for preconditioning and transplantation
9. Adenosine reduces cardiac TNF-alpha production and human myocardial injury following ischemia-reperfusion
10. Pretreatment with IL-1 receptor antagonist reduces ischemia-reperfusion injury in the liver
11. Role of transforming growth factor-β in maintenance of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1
12. Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells
13. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness
14. Detection of interleukin and interleukin-1 receptor mRNA in human heart by polymerase chain reaction
15. Interleukin-1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice
16. Inducible interleukin-1 gene expression in human vascular smooth muscle cells
17. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells
18. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells
19. Interleukin-1 induces interleukin-1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells
20. Shear stress increases the release of interleukin-1 and interleukin-6 by aortic endothelial cells
21. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone
22. Analysis of the role of interleukin-1 βin vivo by gene targeting in embryonic stem cells
23. Rabbit IL-1. Cloning, expression, biologic properties and transcription during endotoxemia
24. Interleukin-1 gene expression in rabbit vascular tissue in vivo
25. Localization of PDGF-B protein in macrophages in all phases of atherogenesis
26. Interleukin-1α as a factor in occlusive vascular disease
27. Interleukin-1β and tumor necrosis factor-α release in normal and diseased human infrarenal aortas
28. Induction of interleukin-1β expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid
29. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1β release from human blood mononuclear cells
30. Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties
31. Interleukin 1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids
32. In vivo blockade of tumor necrosis factor-α in cholesterol fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation
33. Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel
34. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells
35. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells
36. Identification of a membrane-associated interleukin-1 in macrophages
37. Membrane IL-1: IL-1α precursor binds to the plasma membrane via a lectin-like interaction
38. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism
39. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event
40. Activated platelets express IL-1 activity
41. Platelet-derived interleukin-1 induces human endothelial adhesion molecule expression and cytokine production
42. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors
43. Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules
44. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
45. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene
46. Biological basis for interleukin-1 in disease
47. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
48. Treatment of interleukin-1 receptor antagonist in combination with methotrexate in rheumatoid arthritis patients